Online inquiry

IVTScrip™ mRNA-Human ASRGL1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK25727MR)

This product GTTS-WK25727MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ASRGL1 protein. This product can be used in Mitotic fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001083926.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 80150
UniProt ID Q7L266
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASRGL1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK25727MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK12520MR IVTScrip™ mRNA-Human ADCY3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADCY3
GTTS-WK8092MR IVTScrip™ mRNA-Human AGBL4, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AGBL4
GTTS-WK11767MR IVTScrip™ mRNA-Human ABHD17B, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABHD17B
GTTS-WK12483MR IVTScrip™ mRNA-Human ACYP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACYP2
GTTS-WK19253MR IVTScrip™ mRNA-Human AK8, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AK8
GTTS-WK19021MR IVTScrip™ mRNA-Human ALK6, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ALK6
GTTS-WK19892MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK13024MR IVTScrip™ mRNA-Human Acetylcholinesterase, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Acetylcholinesterase
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW